Core Viewpoint - The company, Xianruida Medical-B (06669), has received approval from the National Medical Products Administration of China for its controllable mechanical detachable fiber spring coil, which is designed for embolization of peripheral vascular aneurysms, arteriovenous malformations, and arteriovenous fistulas [1] Product Details - The product features a controllable release mechanism that ensures a stable and precise deployment of the spring coil, enhancing operational controllability and safety [1] - It offers both 2D and 3D structural options, allowing for broad adaptability to clinical needs [1] Market Strategy - The company plans to initiate marketing activities in China at an appropriate time following the product approval [1]
先瑞达医疗-B(06669)：外周可控机械解脱带纤维毛弹簧圈的注册申请获中国国家药品监督管理局批准